Parexel Adaptive Trial Design Brochure

May 7, 2019

No company wants to spend millions of dollars on a protocol, only to receive a negative result at the end of the trial. Nevertheless, that’s exactly what’s happening time and again in the pharmaceutical industry. But what if you could know earlier if your initial assumptions and expectations were off, and you had an opportunity to correct them? The good news is that you can.

Adaptive and Flexible Trial Designs give biopharmaceutical companies the opportunity to reduce the risk of failure by evaluating interim data analysis at pre-defined points and adapting the study design parameters accordingly, in order to optimize the outcome.

Previous Article
Podcast: Drug Development Innovation Through Adaptive Trials
Podcast: Drug Development Innovation Through Adaptive Trials

This PharmaVoice podcast explores adaptive trial designs as a key innovation that, when used, can increase ...

Next Flipbook
Drug Development Innovations that Work: Adaptive Trial Designs
Drug Development Innovations that Work: Adaptive Trial Designs